Thalomid
Active substance: thalidomide
CAPSULE · THALIDOMIDE 200 mg/1
United StatesActive
Marketing holder: Celgene Corporation
Verified 2026-10-09 · openFDA NDC
Analogues in other countries- Source: openFDA NDC
- Countries with the substance registered: 2
Composition
- THALIDOMIDE · 200 mg/1
Analogues by country
Products with the same active substance registered in other countries.
| Country | Products |
|---|---|
| EU 2 |
|
Import and control
Control by country
- United Statesprescription only
Source: openFDA NDC · record 01a12091-f8b7-7580-a0c3-286791867693,01a12098-df5d-7f5d-b0a3-0bb2290321a8,01a1209b-57ed-742a-9529-eb79ef2047e2,01a1209d-a13c-77d4-8e5e-ffb707dcb9b2;count=4 · valid from 2026-10-09 · verified 2026-10-09
Registration
- Registration number
- 59572-220
- Registration status
- Active
- Dispensing
- Prescription only
- Route
- ORAL
Sources
- product · openFDA NDC · 59572-220 · Verified 2026-10-09 · open in source
- registration_status · openFDA NDC · 59572-220 · Verified 2026-10-09 · open in source
- ingredients.0 · openFDA NDC · 59572-220 · Verified 2026-10-09 · open in source